Manufacturing challenges surround the use of IgM monoclonal antibodies, but these can be overcome with current technology.
Richard Richieri
Advertisement
Vice President of Manufacturing and Research and Development at Avid Biosciences, Inc.
Articles by Richard Richieri
Advertisement
Latest Updated Articles
Purification of IgM Monoclonal AntibodiesPublished: March 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
SK pharmteco Invests in California Site to Overcome Peptide Purification Bottlenecks
2
BioPharm Weekly News Roundup—Week of Oct. 20, 2025
3
Orion and Abzena Collaboration Highlights Integrated Antibody Manufacturing Advances
4
